YI (111, Inc) צמיחת רווח למניה משנה לשנה ב-12 החודשים האחרונים
The development of a B2B digital drug distribution platform drives the operational scale of 111, Inc. (YI) in China. The current quarterly EPS pace confirms this growth, with the current level standing at -109.00. An extensive network of automated warehouses guarantees supply stability. Skilled IT personnel and logistics experts, motivated by the digitalization of healthcare, support process efficiency.
YI (111, Inc.): פילוחים אנליטיים ודוחות לפי אינדיקטורים
The assessment of 111, Inc. (YI) margin of safety is based on the dynamics of net earnings per share, which measures the efficiency of capital generation for shareholders over a rolling quarter. By analyzing the trajectory of quarterly EPS growth, an investor can identify business stagnation caused by geopolitical pressure between the US and China, which restricts access to Western investments and complicates the logistics of imported pharmaceuticals.
